Colorectal Cancer

Study affirms safety of oxaliplatin for advanced disease

Published in Clinical Oncology Week, August 18th, 2003

Results from a large multisite study led by University of Pittsburgh Cancer Institute (UPCI) researcher, Ramesh Ramanathan, MD, demonstrate that the drug oxaliplatin is safe for patients with advanced colorectal cancer.

"Our results are encouraging because they affirm that oxaliplatin is safe for patients with advanced colorectal cancer," said Ramanathan, lead investigator and associate professor in the division of hematology/oncology at the University of Pittsburgh School of Medicine. "We found a relatively low occurrence of toxicity from treatment regimens that included oxaliplatin, indicating that it may be a promising option for colorectal patients."

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Clinical Oncology Week

Source: Clinical Oncology Week (2003-08-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry